Personalise your patient’s medication with PGx

Wednesday, 01 July 2020 | Sonic Genetics

Pharmacogenomic (PGx) testing allows you to personalise your patient’s medication according to their genetic variation.

This has been shown to improve clinical outcomes by enhancing therapeutic efficacy and improving clinical safety.

The Sonic PGx Panel is a 10-gene pharmacogenomic test that provides guidance on medication and dose across common therapeutic areas, including cardiology, gastroenterology, pain management, and psychiatry and addiction medicine.

The test detects clinically important genetic variants that affect drug metabolism. These variants modify the rate at which certain drugs are activated or broken down. This information can be used to predict whether a drug or drug dose is likely to be effective and identify patients at risk of serious or intolerable side-effects. Therefore, this testing has a role in identifying patients who may benefit from modified dosing or avoiding a specific drug.

Sonic Genetics noted many Doctors have needed one on one support from Sonic Genetics specialists.

For this reason, Clinpath’s Client Liaison, Jill Hall is now working in partnership with Sonic Genetics, to support Doctors in South Australia. Jill is also open to conversations about Genetic testing, to help with your own understandings of the services and tests which are provided by Sonic Genetics.

There is more information on the website, or simply email or phone Jill to have a discussion.

https://www.sonicgenetics.com.au/tests/pgx/

Jill Hall

BAppSc (MLS)

P: 0408 819 430 | E: jhall@clinpath.com.au